Asaka M, Hirase T, Hashimoto-Komatsu A, Node K. Rab5a-mediated localization of claudin-1 is regulated by proteasomes in endothelial cells. Am J Physiol Cell Physiol 300: C87-C96, 2011. First published October 6, 2010 doi:10.1152/ajpcell.00565.2010.-Tight junctions composed of transmembrane proteins, including claudin, occludin, and tricellulin, and peripheral membrane proteins are a major barrier to endothelial permeability, whereas the role of claudin in the regulation of tight junction permeability in nonneural endothelial cells is unclear. This study demonstrates that claudin-1 is dominantly expressed and depletion of claudin-1 using small interfering RNA (siRNA) increased tight junction permeability in EA hy.926 cells, indicating that claudin-1 is a crucial regulator of endothelial tight junction permeability. The ubiquitin-proteasome system has been implicated in the regulation of endocytotic trafficking of plasma membrane proteins. Therefore, the involvement of proteasomes in the localization of claudin-1 was investigated by pharmacological and genetic inhibition of proteasomes using a proteasome inhibitor, Nacetyl-Leu-Leu-Nle-CHO, and siRNA against the ␤5-subunit of the 20S proteasome, respectively. Claudin-1 was localized at cell-cell contact sites in control cells. Claudin-1 was localized in the cytoplasm in association with Rab5a and EEA-1, a marker of early endosome, following inhibition of proteasomes. Depletion of Rab5a using siRNA reversed the localization of claudin-1 induced by inhibition of proteasomes. These data suggest that proteasomes regulate claudin-1 localization at the plasma membrane, which changes upon proteasomal inhibition to a Rab5a-mediated endosomal localization. endothelial permeability; tight junction TIGHT JUNCTIONS (TJs) are localized at the most apical side of cell-cell contact sites in endothelial cells. TJs seal paracellular routes that regulate movement of ions, H 2 O, and small proteins across cells and contribute to the selective barrier function for endothelial cells (24, 2). TJs also have a fence function that prevents the distribution of lipids and membrane protein between apical and basolateral membranes, and they play a role in maintaining cell polarity in endothelial cells (2, 24) .
endothelial permeability; tight junction TIGHT JUNCTIONS (TJs) are localized at the most apical side of cell-cell contact sites in endothelial cells. TJs seal paracellular routes that regulate movement of ions, H 2 O, and small proteins across cells and contribute to the selective barrier function for endothelial cells (24, 2) . TJs also have a fence function that prevents the distribution of lipids and membrane protein between apical and basolateral membranes, and they play a role in maintaining cell polarity in endothelial cells (2, 24) .
TJs are composed of transmembrane proteins, including claudins, occludin, tricellulin, and junctional adhesion molecule, and peripheral membrane proteins that link transmembrane proteins to actin cytoskeleton (27) . The overexpression of claudin-1 and claudin-2 induces TJ formation in fibroblasts that lack TJs, indicating that claudin is an indispensable membrane protein for the formation and maintenance of TJ structure (12) .
The claudin protein family is composed of 24 members in humans; claudin-1, claudin-3, claudin-5, claudin-12, and claudin-15 are expressed in endothelial cells (3, 10, 19, 29) .
Whereas claudin-1-deficient mice die within 1 day of birth with dysfunction of the epithelial barrier of skin (7), the roles of claudin-1 in vascular endothelium have not been documented. Claudin-5 knockout mice demonstrated that claudin-5 is essential for the size-selective barrier function of TJs in brain endothelial cells that form the blood-brain barrier (19, 21) . Claudin-15 mRNA was detected in mouse kidney endothelial cells by Northern blot analysis (10) , whereas claudin-3 and claudin-12 mRNAs were detected in rat and mouse brain endothelial cells, respectively (3, 29) .
cAMP induces elevated TJ barrier function and claudin-5 phosphorylation via PKA activation in brain endothelial cells (9) . Fujibe et al. (6) reported MAP kinase-dependent threonine phosphorylation of claudin-1 leading to decreased TJ permeability. Therefore, phosphorylation of claudins is involved in the regulation of TJ permeability. Occludin interacts with an ubiquitin ligase named itch and is ubiquitinated, whereas ubiquitination of claudins has not been described (26) . Claudin-3 fused to green fluorescent protein demonstrated internalization of claudin via vesicles during TJ remodeling in live cells (16) . Activation of PKA abrogates the inhibitory effect of the small GTPase Rab13 on the recruitment of claudin-1 to cell-cell junctions (11) . These data indicate that Rab-mediated transport of claudin is implicated in TJ assembly.
The present study investigated the expression of claudin-1 and claudin-5 in EA hy.926 cells, a human endothelial cell line, and investigated the involvement of the ubiquitin-proteasome system in the localization of claudin-1 in EA hy.926 cells by pharmacological and genetic inhibition of proteasomes using a proteasome inhibitor, N-acetyl-Leu-Leu-Nle-CHO (ALLN), and small interfering RNA (siRNA) against the ␤ 5 -subunit of the 20S proteasome, respectively. In addition, the involvement of the small GTPase Rab5a in the determination of claudin-1 localization was studied.
MATERIALS AND METHODS

Materials and antibodies.
Anti-claudin-1 and anti-claudin-5 polyclonal antibodies were purchased from Zymed. Anti-Rab3b, antiRab4a, anti-Rab5a, anti-caveolin-1, and anti-␣-tubulin polyclonal antibodies were purchased from Santa Cruz Biotechnology. Anti-EEA-1 antibody was purchased from Abcam. Anti-ZO-1 antibody was purchased from BD. FITC-conjugated and Alexa Fluor 488-conjugated anti-rabbit IgG antibody and Alexa Fluor 568-conjugated anti-mouse IgG antibody were from Invitrogen (Carlsbad, CA).
Cell culture. The human endothelial cell line EA hy.926 cells was a gift from Dr. Cora-Jean S. Edgell (University of North Carolina at Chapel Hill, Chapel Hill, NC). EA hy.926 cells were maintained at 37°C with 5% CO 2 in DMEM containing 5% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin, as described previously (5) . EA hy.926 cells were obtained by fusing human umbilical vein endothe-lial cells (HUVEC) with the permanent human cell line A549, and express Factor VIII-related antigen (5) .
Reverse transcription PCR. RNA was isolated from EA hy.926 cells and HUVEC with Isogen following the manufacturer's protocol (Nippon Gene). cDNA synthesis was performed using 2 g total RNA and a RETRO script Kit following the manufacturer's protocol (Ambion, Austin, TX). RT-PCR was performed as reported. The specific primer sets for the target genes were as follows: claudin-1, 5=-CCTATGACCCCAGTCAATGC-3= and 5=-GGGAAAGACTACGT-GTGA-3= (GenBank accession no. NM 021101); claudin-3, 5=-TCAC-GTCGCAGAACATCTGG-3= and 5=-GATGGTGATCTTGGCTTGG-3= (GenBank accession no. NM 001306); claudin-5, 5=-TTCGCCAACAT-TGTCGTCC-3= and 5=-TCTTCTTGTCGTAGTCGCCG-3= (GenBank accession no. NM 003277); claudin-12, 5=-TTCCTTCCTGTGTG-GAATCG-3= and 5=-GTTGCACATTCCAATCAGGC-3= (GenBank accession no. NM 012129); and claudin-15, 5=-GCTCATTCCTCTGAC-CTGCC-3= and 5=-ACAGTTGCCATGAAGAAGCC-3= (GenBank accession no. AJ 245738). These primers were synthesized by JBioS (Saitama, Japan). ␤-Actin was amplified using QuantumRNA ␤-actin Internal Standards from Ambion. cDNA was amplified by PCR (claudin-1, claudin-3, and claudin-15, 35 cycles of 30 s at 94°C, 2 min at 59°C, and 1 min of 72°C; claudin-5, 35 cycles of 30 s at 94°C, 2 min at 58°C, and 1 min of 72°C; claudin-12, 35 cycles of 30 s at 94°C, 2 min at 57°C, and 1 min of 72°C). The RT-PCR products were analyzed by agarose gel electrophoresis (2.0%) followed by ethidium bromide staining.
SDS-PAGE and immunoblot analysis. Protein samples were separated by SDS-PAGE (12.5%), and transferred to nitrocellulose membranes. Membranes were blocked with PBS including 0.05% Triton X-100 and 5% nonfat milk powder and incubated with the primary antibody. The membranes were washed and incubated with horseradish peroxidase-conjugated secondary antibody and visualized using enhanced chemiluminescence detection reagents (Amersham).
Immunoprecipitation. Cells were treated with vehicle or 12.5 M ALLN (Calbiochem) at 37°C for 16 h, then lysed with a buffer containing 1% Triton X-100, 250 mM HEPES, 150 mM NaCl, 4 mM EDTA, 10 mM NaF, 1 mM vanadate, and a cocktail of protease inhibitors on ice. Lysates were rotated at 4°C for 30 min, and supernatant was collected by centrifugation for 15 min at 4°C. Ubiquitinated proteins were immunoprecipitated from the lysates with anti-polyubiquitin monoclonal antibody (Stressgen) and protein GSepharose (GE Healthcare). Immunoprecipitates were analyzed by SDS-PAGE and immunoblotting with anti-polyubiquitin monoclonal antibody and anti-claudin-1 antibody.
Immunofluorescence microscopy and confocal microscopy. Cells were fixed with 3% paraformaldehyde and rinsed with PBS. The cells were permeabilized with PBS containing 0.5% Triton X-100. The cells were blocked with PBS containing 1% BSA and incubated with primary antibody. The cells were rinsed and incubated with secondary antibody at room temperature. TO-PRO from Invitrogen was used for nuclear staining. Cells were rinsed and mounted. Images were captured using confocal microscopy (LSM5 Pascal; Zeiss).
Colocalization analysis. The images captured using confocal microscopy (LSM5 Pascal) were opened using ImageJ software (National Institutes of Health, Bethesda, MD), and colocalized pixels were marked using the colocalization finder. The ratios of the number of colocalized to total pixels and area were then calculated.
Preparation of Triton X-100-soluble and Triton X-100-insoluble fractions. EA hy.926 Cells (5 ϫ 10 5 cells) were harvested on a 6-cm dish and cultured overnight. Then, cells were scraped and lysed with a 26-gauge needle in a buffer containing 1% Triton X-100, 250 mM HEPES, 150 mM NaCl, 4 mM EDTA, 10 mM NaF, 1 mM vanadate, and a cocktail of protease inhibitors on ice. Lysates were rotated at 4°C for 30 min. Supernatants were collected by centrifugation (10,000 g for 15 min at 4°C), boiled with Laemmli sample buffer to obtain the Triton X-100-soluble fraction. The pellets were lysed in boiling Laemmli sample buffer and boiled to obtain the Triton X-100-insoluble fraction. Triton X-100-soluble and Triton X-100-insoluble fractions (40 g protein) were analyzed by SDS-PAGE and immunoblotting.
Transfection of siRNA. Claudin-1 Silencer predesigned siRNA (GenBank accession no. U29165. NM-001320, purchased from Ambion) and Rab5a-HSS108976 (Stealth siRNA, no. 113044G04, Invitrogen) were used following the manufacturer's protocol. Transfection of siRNA was performed at a concentration of 100 nM using Lipofectamine 2000 (Invitrogen). Control siRNA for Claudin-1 Silencer predesigned siRNA and Rab5a-HSS108976 were commercially available from Ambion and Invitrogen, respectively. 20S Proteasome ␤5 siRNA (sc-62872) and corresponding control siRNA were purchased from Santa Cruz.
Transcellular electrical resistance measurement. Control and claudin-1-depleted cells were cultured in Transwell two-chamber systems at a density of 1.2 ϫ 10 6 cells/cm 2 . Transcellular electrical resistance (TER) across EA hy.926 cells sheets was measured using an EVOM volt-ohm meter system (World Precision Instruments).
Paracellular flux measurement. Control and claudin-1-depleted cells were cultured in Transwell two-chamber systems at a density of 1.2 ϫ 10 6 cells/cm 2 . FITC-dextran (40-kDa molecular mass) was added to the culture media of the upper chamber at the concentration of 500 g/ml, and cells were incubated for 1 h at 37°C in 5% CO 2. Culture medium (50 l) taken from the lower chamber was used for fluorescence measurement using a microplate reader (Beckman Coulter).
Statistical analysis. Data from five independent experiments are presented as means Ϯ SE. Statistical significance was calculated using the Mann-Whitney's U-test and Wilcoxon's signed-rank test. A value of P Ͻ 0.05 was considered to be significant.
RESULTS
Involvement of claudin-1 in the regulation of TJ permeability in EA hy.926 cells.
Claudin-1, claudin-3, claudin-5, claudin-12, and claudin-15 genes are expressed in endothelial cells (10, 19, 29, 3) . The expression of mRNA for those claudins was examined by RT-PCR in HUVECs and EA hy.926 cells, an immortalized cell line derived from HUVECs (Fig. 1A) . The claudins expressed in EA hy.926 cells were similar to those expressed by HUVECs. Therefore, EA hy.926 cells were used to investigate claudin expression and localization in endothelial cells in this study. Claudin-1 and claudin-5 proteins are expressed in endothelial cells (10, 19, 21) . Immunoblotting demonstrated claudin-1 expression in EA hy.926 cells, whereas claudin-5 was hardly detectable with the same exposure time (Fig. 1B) . Claudin-5 expression was weakly detectable with a longer exposure time. Immunofluorescence revealed that claudin-1 was localized at cell-cell contact sites in EA hy.926 cells, but claudin-5 was hardly detectable in these cell-cell contact sites (Fig. 1B) . These data suggest that claudin-1 is dominantly expressed in EA hy.926 cells.
The effects of claudin-1 depletion using siRNA on TJ permeability were evaluated by measuring TER and paracellular flux to elucidate the involvement of claudin-1 in controlling the TJ permeability of endothelial cells. Immunoblotting showed that transfection with claudin-1 siRNA decreased claudin-1 expression levels adjusted with ␣-tubulin expression levels to 12% of those of control nontransfected cells (Fig. 1C) . The transfection of control siRNA had no obvious effect on claudin-1 expression. Immunofluorescence showed that claudin-1 localization at cell-cell contact sites was hardly detectable in claudin-1-depleted EA hy.926 cells (Fig. 1C) . The transfection of control siRNA had no obvious effect on claudin-1 localization. These data suggest that transfection of claudin-1 siRNA efficiently depleted claudin-1 with the loss of localization at cell-cell contact sites in EA hy.926 cells. TER was measured in control and claudin-1-depleted EA hy.926 cells. Transfection of claudin-1 siRNA, but not of control siRNA, significantly decreased TER in comparison to control cells (Fig. 1D) . Paracellular flux, determined by the passage of a tracer (FITC-dextran) from apical side to basal side, was increased by transfection of claudin-1 siRNA, but not of control siRNA, in comparison to control cells (Fig. 1D ). These data demonstrate that TJ permeability is increased by claudin-1 depletion, suggesting that claudin-1 localized at cell-cell contact sites is a determinant of TJ permeability in EA hy.926 cells.
Involvement of the proteasome system in claudin-1 localization. The ubiquitin-proteasome system regulates not only proteolysis that determines protein levels but also membrane trafficking (4, 8) . The involvement of the ubiquitin-proteasome system in claudin-1 protein levels was examined in EA hy.926 cells. Treatment with ALLN, a proteasome inhibitor, caused no obvious changes in claudin-1 protein levels in whole cell lysates of EA hy.926 cells (Fig. 2A) . However, the claudin-1 protein levels were significantly decreased in the Triton X-100-insoluble fractions and increased in the Triton X-100-soluble fractions in ALLN-treated cells, in comparison to control cells (Fig. 2B) . Immunofluorescence microscopy revealed that claudin-1 was colocalized with ZO-1 at cell-cell contact sites in control EA hy.926 cells. In contrast, punctate staining of claudin-1 was observed in the cytoplasm and localization at cell-cell contact sites of claudin-1 was decreased in ALLNtreated cells (Fig. 2C) . Transfection of siRNA against the ␤ 5 -subunit of the 20S proteasome decreased ␤ 5 -subunit expression levels adjusted with ␣-tubulin expression levels to 49% of those of control nontransfected cells (Fig. 2D) . The depletion of the proteasome ␤ 5 -subunit using siRNA also caused punctate localization of claudin-1 in the cytoplasm, whereas transfection of control siRNA showed no obvious changes in claudin-1 localization in EA hy.926 cells (Fig. 2D) . These data using pharmacological and genetic methods demonstrate that the inhibition of proteasomes causes cytoplasmic localization of claudin-1 in EA hy.926 cells.
Immunoprecipitation with anti-polyubiquitin antibodies failed to sediment claudin-1 from cells treated with control vehicle or with ALLN, demonstrating that claudin-1 is not ubiquitinated in either case (Fig. 3) .
Rab5a-mediated transport of claudin-1. The small GTPase Rab family of proteins plays important roles in intracellular transport and localization of membrane proteins (23) . The expression of Rab3b, Rab4a, and Rab5a was detected in EA hy.926 cells by immunoblotting and immunofluorescence (Fig. 4A) . Colocalization of claudin-1 with Rab3b, Rab4a, or Rab5a was not detected at cell-cell contact sites by confocal microscopy in quiescent EA hy.926 cells (Fig. 4B) . Rab5a, but not Rab3b or Rab4a, was colocalized with claudin-1 in cytoplasm in EA hy.926 cells treated with ALLN (Fig. 4B) . Transfection of siRNA against the ␤ 5 -subunit of the 20S proteasome caused cytoplasmic colocalization of Rab5a, but not Rab3b or Rab4a, with claudin-1 (Fig. 4B) . The degree of fluorophore colocalization was measured by comparing color values for the equivalent pixel position in each of the acquired images as a composite derived from two independent channel single-wave length acquisitions to quantify the colocalization of claudin-1 with the Rab proteins in ALLN-treated cells. ALLN-treated cells showed that 28.7 Ϯ 17.0% and 28.9 Ϯ 17.1% of claudin-1 was colocalized with Rab5a with and without pixel displacement, respectively, whereas colocalization of claudin-1 with Rab3b or Rab4a was hardly detected (Fig. 4C) . These data indicate that Rab5a, but not Rab3b or Rab4a, is involved in claudin-1 transport mediated by proteasomes in EA hy.926 cells.
The internalization of claudin-3 from epithelial TJs is mediated by endocytosis (16) . Claudin-16 is colocalized with EEA-1, an early endosome marker molecule, in Hela cells (20) . Colocalization of claudin-1 and EEA-1 was observed using confocal microscopy to determine whether claudin-1 is localized in early endosomes. As shown in Fig. 5 , cytoplasmic localization of Rab5a without colocalization with EEA-1 was observed in control cells. Claudin-1 was localized at cell-cell contact sites, whereas colocalization of claudin-1 and EEA-1 was not detected in control cells (Fig. 5) . Colocalization of Rab5a with EEA-1 was detected in the cytoplasm after treatment with ALLN. Claudin-1 was localized in the perinuclear region in the cytoplasm in association with EEA-1, but not at cell-cell contact sites, in ALLN-treated cells (Fig. 5) . Rab5a and claudin-1 were colocalized with EEA-1 in the perinuclear region in the cytoplasm of cells transfected with siRNA against the ␤ 5 -subunit of the 20S proteasomes (Fig. 5) . These data indicate that claudin-1 and Rab5a are localized in early endosomes following the inhibition of proteasomes in endothelial cells.
Rab5a was depleted by RNA interference in EA hy.926 cells to investigate the involvement of Rab5a in the localization of claudin-1. A densitometric analysis of immunoblots revealed that transfection of Rab5a siRNA decreased Rab5a expression levels adjusted with ␣-tubulin expression levels to 28% of those of control nontransfected EA hy.926 cells (Fig. 6A ). In addition, immunofluorescence microscopy showed that cytoplasmic Rab5a was decreased by RNA interference (Fig. 6A) . After ALLN treatment, cytoplasmic localization of claudin-1 was detected partly in association with Rab5a in control EA hy.926 cells (Fig. 6B, top left) . Depletion of the ␤ 5 -subunit of the 20S proteasomes also caused similar localization of claudin-1 and Rab5a (Fig. 6B, bottom left) . Rab5a depletion decreased the cytoplasmic localization of claudin-1 induced by ALLN treatment, and depletion of the ␤ 5 -subunit of the 20S proteasomes and claudin-1 was again localized at cell-cell contact sites (Fig. 6B, top right and bottom right) . The degree of fluorophore colocalization was measured in each of the acquired images as a composite derived from two independent channel single-wave length acquisitions (Fig. 6C) . Colocalization measured both with and without pixel displacement demonstrated the colocalization of claudin-1 with Rab5a in ALLNtreated cells, which significantly decreased by depletion of Rab5a using siRNA. These data demonstrate that Rab5a depletion prevents cytoplasmic localization of claudin-1 in early endosomes induced by the inhibition of proteasomes, suggesting that proteasomes are involved in Rab5a-mediated transport of claudin-1 by early endosomes in endothelial cells.
DISCUSSION
TJs seal paracellular pathways that regulate endothelial permeability to maintain the tissue environment. Lysophosphatidic acid and vascular endothelial growth factor (VEGF) caused increased TJ permeability accompanied with relocalization of claudin-5 from cell-cell contact sites in bovine endothelial cells (13, 22) . The current study showed that claudin-1 depletion using siRNA causes increased TJ permeability and loss of claudin-1 localization at cell-cell contact sites. These data suggest that localization of claudin-1 at cell-cell contact sites plays important roles in the maintenance of endothelial permeability.
Transmembrane proteins are recruited to the plasma membrane by transport proteins. Several membrane proteins, such as integrins, VEGF receptor, and epidermal growth factor receptor, are reported to be internalized and recycled back to the plasma membrane. Localization and interaction with associating proteins are important for transmembrane proteins to properly function. VEGF causes the internalization of VEGF receptor 2 with EEA-1-positive endosomes via clathrin-dependent endocytosis, which results in contact-inhibition in endothelial cells (13) . In addition, EFA6, which is an activating factor for the small GTPase Arf6, regulates E-cadherin internalization by early endosomes and is implicated in adherence junction assembly in epithelial cells (25) . Late-endosomemediated transport of claudin-3 is observed in epithelial cells, whereas claudin-16 is colocalized with EEA-1 in Hela cells (16, 20) . Therefore, previous studies have shown that early endosomes are involved in the regulation of cell-cell adhesion through transport of junctional proteins including claudins. The current study found decreased claudin-1 localization at cell-cell contact sites, and colocalization of claudin-1 with EEA-1 in ALLN-treated EA hy.926 cells. These data suggest that proteasomes are involved in early endosome-dependent transport of claudin-1.
Members of the Rab family of small GTPases have been implicated in vesicular transport. Rab21 and Rab5 associated with ␣-integrin chains regulate exo/endocytosis of integrins associated with cell adhesion and migration (23) . Rab13 and Rab3b localize at TJs and contribute to TJ assembly (18, 28) . Morimoto et al. (18) demonstrated that Rab13 specifically mediates the continuous endocytic recycling of occludin to the cell surface in both fibroblasts and epithelial cells. In addition, Rab13 is involved in the transport of claudin-1 from the cytosol to cell-cell junctions and regulates TJ assembly via PKA signaling (11) . Therefore, Rab proteins have been implicated in the regulation of transport of TJ proteins and TJ assembly. As far as we have examined, Rab3b, Rab4a, and Rab5a were expressed in EA hy.926 cells, whereas the expression of Rab11 and Rab13 was hardly detectable (data not shown). Therefore, the colocalization of claudin-1 and Rab3b, Rab4a, and Rab5a was examined in EA hy.926 cells, and we found that claudin-1 and Rab5a in association with EEA-1 were colocalized in ALLN-treated cells, but not in control cells. Rab5a depletion reversed claudin-1 localization in ALLN-treated cells. These data suggest that Rab5a is involved in claudin-1 transport by early endosomes that is regulated by proteasomes.
The ubiquitin-proteasome system plays important roles in regulating protein modification and degradation. Target proteins are ubiquitinated by ubiquitin-activating enzyme (E1), ubiquitin-conjugating enzyme (E2), and E3 ubiquitin ligase (4, 8) . Ubiquitination of plasma membrane proteins is a mechanism to control their endocytic trafficking by promoting their interaction with cytosolic proteins that contain ubiquitin-binding domains. Traweger et al. (26) demonstrated that itch, an E3 ubiquitin ligase, interacts with occludin and is involved in ubiquitination of occludin. In addition, cAMP induces itch expression that triggers occludin ubiquitination resulting in TJ disruption (15) . Therefore, ubiquitination of TJ membrane proteins may be involved in the regulation of TJ assembly/ disassembly, whereas ubiquitination of claudins has not been observed.
Although the present study indicates Rab5a-mediated transport of claudin-1 by early endosomes, the mechanism of proteasome-regulated Rab5a-mediated transport is unclear. Recently, it was shown that Rabex-5, a guanine nucleotide exchange factor (GEF) for Rab5 that forms a complex on endosomes with Rabaptin-5, has ubiquitin ligase (E3) activity (14, 17) . The binding of Rabaptin-5 increases GEF activity of Rabex-5 and enhances endosome fusion (14) . Accordingly, Rab5-Rabex-5-Rabaptin-5 complexes on endosomes may regulate ubiquitination and transport of target proteins. The current study indicates that claudin-1 is not ubiquitinated. Therefore, there is a possibility that proteasomes regulate claudin-1 localization by the proteolysis of claudin-1-associating proteins that are ubiquitination targets of the Rab5-Rabex-5-Rabaptin-5 complex and, as a result, control the formation of the claudin-1-Rab5a protein complex. On the other hand, ubiquitin-independent proteolysis by proteasomes occurs in the degradation of ornithine decarboxylase and p53 (1, 30) . Accordingly, we also raise another possibility that proteasomes regulate claudin-1 localization by ubiquitin-independent proteolysis of claudin-1-associating proteins that determine claudin-1 localization. Therefore, proteasomes may be involved in the regulation of transport and degradation of claudin-1 protein complexes that determine claudin-1 localization at cell-cell contact sites. Further studies are necessary to elucidate physiological relevance of Rab5a-EEA-1-proteasome-mediated claudin-1 transport in the control of tight junction permeability by specifically inhibiting Rab5a-EEA-1-proteasome-mediated claudin-1 transport in endothelial cells both in vitro and in vivo.
In conclusion, the present study suggests that Rab5a in early endosomes is implicated in proteasome-mediated localization of claudin-1 at cell-cell contacts in endothelial cells. Rab5a-mediated claudin-1 transport may play a role in the regulation of endothelial TJ permeability.
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